IL6 and bacterial infectious disease with sepsis: Controlling the intracellular response to IL-6 by promoting the required signaling arm and limiting unnecessary responses (e.g., antiviral genes in response to bacteremia) is a promising therapeutic avenue to reduce the risk of multiorgan dysfunction without impeding pathogen clearance.